This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Stephen E. Jones, MD
The University of Arizona Health Sciences Center Tucson

JAMA. 1981;245(15):1527-1528.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

How can there be a "consensus" when all relevant information is not presented?

I wish to clarify several points attributed to me in the recent MEDICAL NEWS article (1980;244:1079) on the National Cancer Institute Consensus Conference on Adjuvant Chemotherapy of Breast Cancer.¹

Regarding the use of adjuvant chemotherapy for node-negative (stage I) cases, I reported on the preliminary results of a pilot study wherein two patients have relapsed out of 52 treated with adjuvant chemotherapy. At no time during the conference did I advocate the routine use of adjuvant chemotherapy in this setting—I repeatedly stated that this is an on-going research program and that the preliminary results should be judged on their own merits. Since many larger groups of investigators (eg, cooperative groups) are now just initiating controlled trials for stage I cases, the data we presented from our pilot program might provide some background and . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?